长链非编码RNA TSLNC8是一种抑癌因子,可失活白细胞介素-6/STAT3信号通路
该研究发现长链非编码RNA TSLNC8在肝细胞癌组织中频繁缺失并下调,其缺失与肝细胞癌恶性特征高度相关,并可作为预后指标。TSLNC8通过竞争性结合转酮醇酶与STAT3,调节STAT3磷酸化水平及转录活性,从而失活白细胞介素-6-STAT3信号通路,抑制肝细胞癌细胞的增殖与转移。
要点
- TSLNC8在肝细胞癌组织中频繁缺失并下调,其缺失与肝细胞癌恶性特征高度相关,可作为预后指标。
- TSLNC8通过竞争性结合转酮醇酶与STAT3,调节STAT3-Tyr705和STAT3-Ser727磷酸化水平及STAT3转录活性。
- TSLNC8在体外和体内均显著抑制肝细胞癌细胞的增殖与转移,TSLNC8-转酮醇酶-STAT3轴是潜在治疗靶点。
核心结论
- TSLNC8是肝细胞癌患者有前景的预后预测因子,TSLNC8-转酮醇酶-STAT3轴是肝细胞癌治疗的潜在靶点。
研究设计与样本
- 研究报道了一种位于染色体8p12的新型抑癌长链非编码RNA TSLNC8,在肝细胞癌组织中频繁缺失并下调,并进行了体外和体内功能实验。
主要发现
- TSLNC8在肝细胞癌组织中频繁缺失并下调,其缺失与肝细胞癌恶性特征高度相关,并可作为肝细胞癌患者的预后指标。
- TSLNC8在体外和体内显著抑制肝细胞癌细胞的增殖与转移。
- TSLNC8通过竞争性结合转酮醇酶与STAT3,调节STAT3-Tyr705和STAT3-Ser727磷酸化水平及STAT3转录活性,从而失活肝细胞癌细胞中的白细胞介素-6-STAT3信号通路。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Long noncoding RNAs can serve as oncogenes or tumor suppressors in human cancer; however, their biological functions and underlying mechanism in hepatocarcinogenesis are largely unknown. Here, we report a novel tumor suppressor long noncoding RNA on chromosome 8p12 (termed TSLNC8) that is frequently deleted and down-regulated in hepatocellular carcinoma (HCC) tissues. The loss of TSLNC8 is highly associated with the malignant features of HCC and serves as a prognostic indicator for HCC patients. TSLNC8 significantly suppresses the proliferation and metastasis of HCC cells in vitro and in vivo. TSLNC8 exerts its tumor suppressive activity by competitively interacting with transketolase and signal transducer and activator of transcription 3 (STAT3) and modulating the STAT3-Tyr705 and STAT3-Ser727 phosphorylation levels and STAT3 transcriptional activity, thus resulting in inactivation of the interleukin-6-STAT3 signaling pathway in HCC cells. CONCLUSION: TSLNC8 is a promising prognostic predictor for patients with HCC, and the TSLNC8-transketolase-STAT3 axis is a potential therapeutic target for HCC treatment. (Hepatology 2018;67:171-187).
引用
- Zhang J, Li Z, Liu L, et al. Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway. Hepatology. 2017. PMID: 28746790. doi:10.1002/hep.29405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。